Current Treatment Options in Neurology . 2015Narula S, Hopkins SE, Banwell B. Treatment of pediatric multiple sclerosis. Curr Treat Options Neurol 2015;17:336.Narula S, Hopkins S, Banwell B (2015) Treatment of Pediatric Multiple Sclerosis. Curr Treat Options Neurol 17: 1-10....
sclerosisStatinTreatmentCurrent treatments for relapsing remitting multiple sclerosis (RRMS) reduce inflammation, but have a partial or modest effect on ... Roberta,Lanzillo,Marcello,... - 《Multiple Sclerosis & Related Disorders》 被引量: 0发表: 2019年 Applying causal models to explore the mechanism...
Articles added consectively to current annual volume. Also issued in print.《Multiple Sclerosis International》2015年Volume 2015共发表18篇文献,掌桥科研收录2010年以来所有《Multiple Sclerosis International》期刊内所有文献。
Multiple sclerosis (MS) is the commonest cause of disability in young adults. While there is increasing choice and better treatments available for delaying disease progression, there are still, very few, effective symptomatic treatments. For many patients such as those with primary progressive MS (...
Multiple Sclerosis Treatments for Relapses While MS affects everyone differently, relapsing-remitting MS causes periods of disease flares. You may recover between these flares (also called remission). Sometimes, all your symptoms go away, but at other times a few symptoms may persist. ...
Multiple sclerosis (MS) is the most common chronic inflammatory, demyelinating and neurodegenerative disease of the central nervous system in young adults. This disorder is a heterogeneous, multifactorial, immune-mediated disease that is influenced by both genetic and environmental factors. In most patien...
Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study... Multiple Sclerosis Therapy With Disease- Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study...
Multiple sclerosis affects 2.5 million people worldwide, including 400,000 Americans. Get in-depth multiple sclerosis information here on symptoms and treatments of MS.
While not all multiple sclerosis (MS) relapses require treatment, relapses that are bothersome or that impair function should prompt consideration of timel
Due to the heterogeneous nature of the disease, it is a challenge to capture disease activity of multiple sclerosis (MS) in a reliable and valid way. There